The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by NEOS Investment Management LLC

NEOS Investment Management LLC raised its position in The Cooper Companies, Inc. (NASDAQ:COO) by 24.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 6,252 shares of the medical device company’s stock after buying an additional 1,237 shares during the quarter. NEOS Investment Management LLC’s holdings in Cooper Companies were worth $575,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Cooper Companies during the fourth quarter worth about $691,000. Highland Capital Management LLC acquired a new position in Cooper Companies during the 4th quarter worth approximately $4,004,000. Caprock Group LLC purchased a new position in shares of Cooper Companies during the 4th quarter worth approximately $282,000. Franklin Resources Inc. lifted its holdings in shares of Cooper Companies by 194.0% in the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after buying an additional 32,260 shares during the period. Finally, Principal Financial Group Inc. boosted its stake in shares of Cooper Companies by 6.6% in the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock valued at $26,295,000 after buying an additional 14,687 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the subject of several research analyst reports. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Stifel Nicolaus reduced their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup reduced their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Finally, Robert W. Baird lowered their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Trading Down 1.4 %

Shares of COO opened at $83.77 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38. The stock has a market cap of $16.75 billion, a price-to-earnings ratio of 42.96, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The firm has a 50 day simple moving average of $89.33 and a 200-day simple moving average of $97.21.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.